NCT00976495 Effects of Dapagliflozin on Kidney Function (Glomerular Filtration Rate) in Subjects With Type 2 Diabetes Status COMPLETED Phase PHASE2
NCT00975533 Gastric Modulator (TANTALUS® System) Versus Insulin Treatment in Obese Type 2 Diabetic Patients - a Randomized Control Trial Status UNKNOWN Phase PHASE3
NCT00975286 24-week Treatment With Lixisenatide in Type 2 Diabetes Insufficiently Controlled With Metformin and Insulin Glargine Status COMPLETED Phase PHASE3
NCT00975065 Galvus on Met Phase 4 Study : Study to Evaluate the Efficacy and Safety of Early Combination of Vildagliptin and Metformin in Patients With Type 2 Diabetes Mellitus Status COMPLETED Phase PHASE4
NCT00974272 Effects of Exenatide on Postprandial Hyperlipidemia and Inflammation Status COMPLETED Phase PHASE4
NCT00974090 Efficacy and Safety Study of MP-513 in Combination With Sulfonylurea in Patients With Type 2 Diabetes Status COMPLETED Phase PHASE3
NCT00972322 Pharmacokinetics and Pharmacodynamics of MK-8245 in Participants With Type 2 Diabetes (MK-8245-012) Status COMPLETED Phase PHASE1
NCT00972244 Trial to Evaluate the Efficacy and Safety of Dapagliflozin in Japanese Type 2 Diabetes Mellitus Patients Status COMPLETED Phase PHASE2
NCT00971243 Efficacy and Safety of MP-513 in Combination With Metformin in Patients With Type 2 Diabetes Status COMPLETED Phase PHASE2
NCT00968786 Home Monitoring in the Management of Hypertension and Diabetes Mellitus Status UNKNOWN Phase NA
NCT00964262 A Study to Evaluate Safety and Pharmacokinetics/Pharmacodynamics of Sustained Release(SR) Exenatide Status COMPLETED Phase PHASE1
NCT00960661 A Trial Comparing Two Therapies: Basal Insulin/Glargine, Exenatide and Metformin Therapy (BET) or Basal Insulin/Glargine, Bolus Insulin Lispro and Metformin Therapy (BBT) in Subjects With Type 2 Diabetes Status COMPLETED Phase PHASE3
NCT00958269 Study to Evaluate Safety and Efficacy of Dutogliptin in Type 2 Diabetes Mellitus Subjects With Moderate and Severe Renal Impairment Status TERMINATED Phase PHASE3
NCT00951912 The Effects of Soy Isoflavones to Improve the Metabolism of Glucose and Lipids Status COMPLETED Phase NA
NCT00949663 Xenin-25: Novel Regulator of Insulin Secretion and Beta-cell Function Status COMPLETED Phase PHASE1
NCT00948493 Treatment Use of Generex Oral-lyn™ in Patients With Diabetes Status NO_LONGER_AVAILABLE Phase N/A
NCT00948324 Effect of Intensive Therapy Associated With CSII on β-cell Function With Newly Diagnosed Type 2 Diabetes Status SUSPENDED Phase PHASE4